Citations

Clear

171 citation(s) found for "Moss, M".

Pretransplant Fasting Glucose Predicts New-Onset Diabetes after Liver Transplantation
Carey, Elizabeth J. , Aqel, Bashar , Byrne, Thomas , Douglas, David D., Rakela, Jorge , Vargas, Hugo E. , Moss, Adyr A. , Reddy, Kunam S. , Chakkera, Harini A. , Aqel, Bashar A. , Mulligan, David C. , Vargas, Hugo E , Chakkera, Harini A

Mayo Clinic

Journal of Transplantation | January 29, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-6

10.1155/2012/614781 | PMID 22461975 Get It

New-onset diabetes after transplantation (NODAT) is common after liver transplant and associated with poorer outcomes. The aim of this study was to identify risk factors for NODAT in liver transplant recipients off corticosteroids. In 225 adult nondiabetic liver transplant recipients, the mean age was 51.7 years, the majority were men (71%), and half had HCV (49%). The mean calculated MELD score at transplantation was 18.7, and 19% underwent living-donor transplant (LDLT). One year after transplantation, 17% developed NODAT, and an additional 16% had impaired fasting glucose. The incidence of NODAT in patients with HCV was 26%. In multivariate analysis, HCV, pretransplant FPG, and LDLT were significant. Each 10 mg/dL increase in pretransplant FPG was associated with a twofold increase in future development of NODAT. The incidence of NODAT after liver transplant in patients off corticosteroids is 17%. Risk factors for developing NODAT include HCV and pretransplant FPG; LDLT is protective.
Reducing PICU Central Line–Associated Bloodstream Infections: 3-Year Results
Miller, Marlene R. , Niedner, Matthew , Huskins, W. Charles , Colantuoni, Elizabeth, Yenokyan, Gayane , Moss, Michele , Rice, Tom B. , Ridling, Debra , Campbell, Deborah, Brilli, Richard J., Huskins, W Charles

Mayo Clinic

Pediatrics | October 25, 2011 | Volume: 128 | Issue: 5 | Pages: e1077-e1083

10.1542/peds.2010-3675 | PMID 22025594 Get It

OBJECTIVES: To evaluate the long-term impact of pediatric central line care practices in reducing PICU central line–associated bloodstream infection (CLA-BSI) rates and to evaluate the added impact of chlorhexidine scrub and chlorhexidine-impregnated sponges. METHODS: A 3-year, multi-institutional, interrupted time-series design (October 2006 to September 2009), with historical control data, was used. A nested, 18-month, nonrandomized, factorial design was used to evaluate 2 additional interventions. Twenty-nine PICUs were included. Two central line care bundles (insertion and maintenance bundles) and 2 additional interventions (chlorhexidine scrub and chlorhexidine-impregnated sponges) were used. CLA-BSI rates (January 2004 to September 2009), insertion and maintenance bundle compliance rates (October 2006 to September 2009), and chlorhexidine scrub and chlorhexidine-impregnated sponge compliance rates (January 2008 to June 2009) were assessed. RESULTS: The average aggregate baseline PICU CLA-BSI rate decreased 56% over 36 months from 5.2 CLA-BSIs per 1000 line-days (95% confidence interval [CI]: 4.4–6.2 CLA-BSIs per 1000 line-days) to 2.3 CLA-BSIs per 1000 line-days (95% CI: 1.9–2.9 CLA-BSIs per 1000 line-days) (rate ratio: 0.44 [95% CI: 0.37–0.53]; P < .0001). No statistically significant differences in CLA-BSI rate decreases between PICUs using or not using either of the 2 additional interventions were found. CONCLUSIONS: Focused attention on consistent adherence to the use of pediatrics-specific central line insertion and maintenance bundles produced sustained, continually decreasing PICU CLA-BSI rates. Additional use of either chlorhexidine for central line entry scrub or chlorhexidine-impregnated sponges did not produce any statistically significant additional reduction in PICU CLA-BSI rates.
Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation
Chakkera, Harini A. , Weil, E. Jennifer , Swanson, Christine M. , Dueck, Amylou C. , Heilman, Raymond L. , Reddy, Kunam S. , Hamawi, Khaled, Khamash, Hasan , Moss, Adyr A. , Mulligan, David C. , Katariya, Nitin , Knowler, William C. , Dueck, A. C. , Katariya, Nitin N , Chakkera, Harini A

Mayo Clinic

Diabetes Care | September 23, 2011 | Volume: 34 | Issue: 10 | Pages: 2141-2145

10.2337/dc11-0752 | PMID 21949218 Get It

OBJECTIVE New-onset diabetes after kidney transplantation (NODAT) has adverse clinical and economic implications. A risk score for NODAT could help identify research subjects for intervention studies. RESEARCH DESIGN AND METHODS We conducted a single-center retrospective cohort study using pretransplant clinical and laboratory measurements to construct a risk score for NODAT. NODAT was defined by hemoglobin A1c (HbA1c) ≥6.5%, fasting serum glucose ≥126 mg/dL, or prescribed therapy for diabetes within 1 year posttransplant. Three multivariate logistic regression models were constructed: 1) standard model, with both continuous and discrete variables; 2) dichotomous model, with continuous variables dichotomized at clinically relevant cut points; and 3) summary score defined as the sum of the points accrued using the terms from the dichotomous model. RESULTS A total of 316 subjects had seven pretransplant variables with P < 0.10 in univariate logistic regression analyses (age, planned corticosteroid therapy posttransplant, prescription for gout medicine, BMI, fasting glucose and triglycerides, and family history of type 2 diabetes) that were selected for multivariate models. Areas under receiver operating curves for all three models were similar (0.72, 0.71, and 0.70). A simple risk score calculated as the sum of points from the seven variables performed as well as the other two models in identifying risk of NODAT. CONCLUSIONS A risk score computed from seven simple pretransplant variables can identify risk of NODAT.
Risk of Syncope in Family Members Who Are Genotype-Negative for a Family-Associated Long-QT Syndrome Mutation
Barsheshet, Alon , Moss, Arthur J. , McNitt, Scott , Polonsky, Slava, Lopes, Coeli M. , Zaręba, Wojciech , Ackerman, Michael J. , Benhorin, Jesaia, Kaufman, Elizabeth S. , Towbin, Jeffrey A. , Vincent, G. Michael, Qi, Ming , Robinson, Jennifer L. , Goldenberg, Ilan , Zareba, Wojciech

Mayo Clinic

Circulation: Cardiovascular Genetics | August 11, 2011 | Volume: 4 | Issue: 5 | Pages: 491-499

10.1161/circgenetics.111.960179 | PMID 21831960 Get It

Background—Current clinical diagnosis of long-QT syndrome (LQTS) includes genetic testing of family members of mutation-positive patients. The present study was designed to assess the clinical course of individuals who are found negative for the LQTS-causing mutation in their families.Methods and Results—Multivariate Cox proportional hazards model was used to assess the risk for cardiac events (comprising syncope, aborted cardiac arrest [ACA], or sudden cardiac death [SCD]) from birth through age 40 years among 1828 subjects from the LQTS Registry who were found negative for their family LQTS-causing mutation. The median QTc of study subjects was 423 ms (interquartile range, 402–442 ms). The cumulative probability of a first syncope through age 40 years was 15%. However, only 2 patients (0.1%) had ACA, and none died suddenly during follow-up. Independent risk factors for syncope in genotype-negative subjects included female sex (hazard ratio [HR], 1.60;P=0.002), prolonged QTc (HR=1.63 per 100 ms increment,P=0.02), family history of ACA or SCD (HR=1.89,P=0.002), and LQT2 versus LQT1 family mutation (HR=1.41,P=0.03). Subgroup analysis showed that the presence of theK897Tpolymorphism in the LQT2 gene in an affected family was associated with an 11-fold (P=0.001) increase in the risk of recurrent syncope in genotype-negative subjects.Conclusions—Our findings suggest that cardiac events among genotype-negative family members of LQTS patients are dominated by nonfatal syncopal episodes without occurrence of sudden cardiac death. The risk for nonfatal events in this population may be mediated by the presence of common polymorphisms in LQTS genes.
Living donor kidney transplantation with multiple renal arteries in the laparoscopic era
Tyson, MD, Castle, EP, Ko, Edmund , Andrews, PE, Heilman, R., Mekeel, K., Moss, AA, Mulligan, David C. , Reddy, K. Srinath

Mayo Clinic

International braz j urol | August 5, 2011 | Volume: 37 | Issue: 3 | Pages: 401-402

10.1590/s1677-55382011000300018 Get It

Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2
Buber, Jonathan , Mathew, Jehu, Moss, Arthur J. , Barsheshet, Alon , McNitt, Scott , Zaręba, Wojciech , Ackerman, Michael J. , Kaufman, Elizabeth S. , Luria, David , Eldar, Michael, Towbin, Jeffrey A. , Vincent, Michael, Hall, William Jackson , Robinson, Jennifer L. , Goldenberg, Ilan , Zareba, Wojciech

Mayo Clinic

Circulation | June 1, 2011 | Volume: 123 | Issue: 24 | Pages: 2784-2791

10.1161/circulationaha.110.000620 | PMID 21632495 Get It

Background—Women with congenital long-QT syndrome experience an increased risk for cardiac events after the onset of adolescence that is more pronounced among carriers of the LQT2 genotype. We hypothesized that the hormonal changes associated with menopause may affect clinical risk in this population.Methods and Results—We used a repeated-events analysis to evaluate the risk for recurrent syncope during the menopause transition and postmenopausal periods (5 years before and after the age at onset of menopause, respectively) among 282 LQT1 (n=151) and LQT2 (n=131) women enrolled in the Long-QT Syndrome Registry. Multivariate analysis showed that the risk for recurrent syncope (n=150) among LQT2 women was significantly increased during both menopause transition (hazard ratio, 3.38;P=0.005) and the postmenopausal period (hazard ratio, 8.10;P<0.001) compared with the reproductive period. The risk increase was evident among women who did or did not receive estrogen therapy. In contrast, among LQT1 women, the onset of menopause was associated with a reduction in the risk for recurrent syncope (hazard ratio, 0.19;P=0.05;P=0.02 for genotype-by-menopause interaction). Only 22 women (8%) experienced aborted cardiac arrest or sudden cardiac death during follow-up. The frequency of aborted cardiac arrest/sudden cardiac death showed a similar genotype-specific association with the onset of menopause.Conclusions—The onset of menopause is associated with a significant increase in the risk of cardiac events (dominated by recurrent episodes of syncope) in LQT2 women, suggesting that careful follow-up and continued long-term therapy are warranted in this population.
Impact of Acute Rejection on Kidney Allograft Outcomes in Recipients on Rapid Steroid Withdrawal
Heilman, Raymond L. , Nijim, S., Chakkera, Harini A. , Devarapalli, Y., Moss, Adyr A. , Hamawi, K., Williams, J. W. , Reddy, Kunam S. , Mulligan, David C. , Mazur, Marta , Chakkera, Harini A

Mayo Clinic

Journal of Transplantation | May 15, 2011 | Volume: 2011 | Issue: No issue available | Pages: 1-8

10.1155/2011/583981 | PMID 21647349 Get It

Background. Our aim was to study the impact of clinical acute rejection (CR) and subclinical rejection (SR) on outcomes in kidney transplant recipients treated with rapid steroid withdrawal (RSW).Methods. All patients who received a living or deceased donor kidney transplant and were treated with RSW were included. The primary outcome was death-censored graft survival. Biopsies with Banff borderline changes were included with the rejection groups.Results. 457 kidney transplant recipients treated with RSW were included; 46 (10%) experienced SR, and 36 (7.8%) had CR. Mean HLA mismatch was significantly higher in the CR group. The Banff grade of rejection was higher in the CR group. There was a larger proportion of patients in both rejection groups with the combination of IFTA and persistent inflammation on the follow-up protocol biopsy done at 1 year. The estimated 5-year death-censored graft survival was 81% in SR, 78% in CR, and 97% in the control group (P<.0001). Significant differences were observed in allograft survival between the CR and control group (HR 9.06, 95% CI 3.39–24.2) and between the SR and control group (HR 4.22, 95% CI 1.30–13.7).Conclusion. Both SR and CR are associated with an inferior graft survival in recipients on RSW.
Early Graft Function After Laparoscopically Procured Living Donor Kidney Transplantation
Tyson, Mark D. , Castle, Erik P., Andrews, Paul E. , Heilman, Raymond L. , Mekeel, Kristin L. , Moss, Adyr A. , Mulligan, David C. , Reddy, Kunam S.

Mayo Clinic

Journal of Urology | August 20, 2010 | Volume: 184 | Issue: 4 | Pages: 1434-1439

10.1016/j.juro.2010.06.013 | PMID 20727548 Get It

Successful Transplantation of a Split Crossed Fused Ectopic Kidney into a Patient with End-Stage Renal Disease
Mekeel, Kristin L. , Daley, Shane M., Andrews, Paul E. , Moss, Adyr A. , Heilman, Raymond L. , Mazur, Marek J., Chakkera, Harini A. , Hamawi, Khalid, Reddy, Kunam S. , Hamawi, Khalid, Mulligan, David C. , Chakkera, Harini A

Mayo Clinic

Journal of Transplantation | March 25, 2010 | Volume: 2010 | Issue: No issue available | Pages: 1-5

10.1155/2010/383972 | PMID 20368777 Get It

Potential donors with congenital renal anomalies but normal renal function are often overlooked because of a possible increase in technical difficulty and complications associated with the surgery. However, as the waiting list for a deceased donor kidney transplant continues to grow, it is important to consider these kidneys for potential transplant. This paper describes the procurement of a crossed fused ectopic kidney, and subsequent parenchymal transection prior to transplantation as part of a combined simultaneous kidney pancreas transplant. The transplant was uncomplicated, and the graft had immediate function. The patient is now two years from transplant with excellent function.
The International LAM Registry: A Component of an Innovative Web-Based Clinician, Researcher, and Patient-Driven Rare Disease Research Platform
Nurok, Michael , Eslick, Ian , Carvalho, Carlos Roberto Ribeiro de , Costabel, Ulrich , Glanville, Allan R. , Harari, Sergio , Johnson, Simon R. , Lacronique, J, Lazor, Romain , Moss, Joel , Ruoss, Stephen J. , Ryu, Jay H. , Seyama, Kuniaki , Watz, Henrik, Hohmann, Elizabeth , Moss, Frank, D'Armiento, Jeanine M , Henske, Elizabeth P. , Inoue, Yoshikazu , Xu, Kai‐Feng , Ryu, Jay H

Mayo Clinic

Lymphatic Research and Biology | March 17, 2010 | Volume: 8 | Issue: 1 | Pages: 81-87

10.1089/lrb.2009.0028 | PMID 20235890 Get It